Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease
暂无分享,去创建一个
[1] M. Beal,et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.
[2] P. Calabresi,et al. Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons , 1997, The Journal of Neuroscience.
[3] P. Calabresi,et al. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones , 1997, British journal of pharmacology.
[4] J. Urenjak,et al. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy , 1997, Progress in Neurobiology.
[5] P. Somogyi,et al. Cellular, Subcellular, and Subsynaptic Distribution of AMPA-Type Glutamate Receptor Subunits in the Neostriatum of the Rat , 1997, The Journal of Neuroscience.
[6] J. Lübke,et al. Functional Properties of AMPA and NMDA Receptors Expressed in Identified Types of Basal Ganglia Neurons , 1997, The Journal of Neuroscience.
[7] R. Albin,et al. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons , 1996, Neuroscience.
[8] A. Reiner,et al. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity , 1996, Neuroscience.
[9] D. Surmeier,et al. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. , 1996, Molecular pharmacology.
[10] Charles J. Wilson,et al. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] R. Lanius,et al. Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C. , 1996, Trends in pharmacological sciences.
[12] P. Calabresi,et al. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia , 1996, Trends in Neurosciences.
[13] Charles J. Wilson,et al. Striatal interneurones: chemical, physiological and morphological characterization , 1995, Trends in Neurosciences.
[14] P. Jonas,et al. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels , 1995, Neuron.
[15] M. Beal,et al. Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.
[16] P. Calabresi,et al. Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase , 1995, The European journal of neuroscience.
[17] P. Calabresi,et al. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. , 1995, Brain : a journal of neurology.
[18] G. Landwehrmeyer,et al. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[19] K. Lees,et al. Clinical experience with excitatory amino acid antagonist drugs. , 1995, Stroke.
[20] C. Hammond,et al. Anoxic LTP sheds light on the multiple facets of NMDA receptors , 1994, Trends in Neurosciences.
[21] A. Cowan,et al. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? , 1994, Trends in Neurosciences.
[22] J. Penney,et al. Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat , 1994, The Journal of comparative neurology.
[23] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[24] B. Sakmann,et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.
[25] J. Walsh,et al. Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro , 1994, Neuroscience.
[26] M. DiFiglia,et al. Intrastriatal Injections of Quinolinic Acid or Kainic Acid: Differential Patterns of Cell Survival and the Effects of Data Analysis on Outcome , 1993, Experimental Neurology.
[27] Y. Kawaguchi,et al. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[29] P. Seeburg. The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels , 1993, Trends in Neurosciences.
[30] R. Huganir,et al. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain , 1993, Nature.
[31] T. Dawson,et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] G Bernardi,et al. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. , 1993, Brain : a journal of neurology.
[33] R. Huganir,et al. AMPA glutamate receptor subunits are differentially distributed in rat brain , 1993, Neuroscience.
[34] J. Bolam,et al. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat , 1992, Neuroscience.
[35] Y. Ben-Ari,et al. Protein kinase C modulation of NMDA currents: an important link for LTP induction , 1992, Trends in Neurosciences.
[36] Y. Kawaguchi,et al. Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. , 1992, Journal of neurophysiology.
[37] R. Albin,et al. Alternative excitotoxic hypotheses , 1992, Neurology.
[38] M. Beal,et al. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.
[39] R. North,et al. Membrane properties and synaptic responses of rat striatal neurones in vitro. , 1991, The Journal of physiology.
[40] M. Beal,et al. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] H. Takagi,et al. Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum , 1991, Brain Research.
[42] P. Calabresi,et al. Kainic acid on neostriatal neurons intracellularly recorded in vitro: electrophysiological evidence for differential neuronal sensitivity , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] R. Huganir,et al. Regulation of neurotransmitter receptor desensitization by protein phosphorylation , 1990, Neuron.
[44] K. Polsky,et al. Ischemic damage in the striatum of adult gerbils: Relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons , 1990, Experimental Neurology.
[45] J. Garthwaite,et al. Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.
[46] D. Choi. Cerebral hypoxia: some new approaches and unanswered questions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] Marian DiFiglia,et al. Excitotoxic injury of the neostriatum: a model for Huntington's disease , 1990, Trends in Neurosciences.
[48] A. Graybiel. Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.
[49] G Bernardi,et al. Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. , 1990, Journal of neurophysiology.
[50] S. T. Kitai,et al. Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[52] R. Schwarcz,et al. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system , 1989, Neuroscience Letters.
[53] R. S. Sloviter. Calcium‐binding protein (calbindin‐D28k) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity , 1989, The Journal of comparative neurology.
[54] R. Auer,et al. Biological differences between ischemia, hypoglycemia, and epilepsy , 1988, Annals of neurology.
[55] D. Choi,et al. Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.
[56] J. Penney,et al. NMDA receptor losses in putamen from patients with Huntington's disease. , 1988, Science.
[57] S. W. Davies,et al. Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum , 1988, Neuroscience.
[58] K. Horikawa,et al. A versatile means of intracellular labeling: injection of biocytin and its detection with avidin conjugates , 1988, Journal of Neuroscience Methods.
[59] A. Novelli,et al. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.
[60] D. Choi,et al. Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists , 1988, Brain Research.
[61] Joseph B. Martin,et al. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease , 1987, Brain Research.
[62] Joseph B. Martin,et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.
[63] J. B. Martin,et al. Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.
[64] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[65] T. Kita,et al. Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation , 1984, Brain Research.
[66] W. Pulsinelli,et al. The response of GABAergic and cholinergic neurons to transient cerebral ischemia , 1982, Brain Research.
[67] Fred Plum,et al. Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.
[68] S. T. Kitai,et al. Medium spiny neuron projection from the rat striatum: An intracellular horseradish peroxidase study , 1980, Brain Research.
[69] P. Mcgeer,et al. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids , 1976, Nature.
[70] M. Fisher,et al. Delayed Treatment with a Noncompetitive NMDA Antagonist, CNS-1102, Reduces Infarct Size in Rats , 1994 .
[71] S. Heinemann,et al. Cloned glutamate receptors. , 1994, Annual review of neuroscience.
[72] M. Hollmann,et al. Molecular neurobiology of glutamate receptors. , 1992, Annual review of physiology.
[73] D. Choi,et al. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. , 1990, Annual review of neuroscience.
[74] A. Lang,et al. Hypoxic‐ischemic damage of the basal ganglia case reports and a review of the literature , 1990, Movement disorders : official journal of the Movement Disorder Society.
[75] G Bernardi,et al. Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. , 1990, Journal of neurophysiology.
[76] B. Meldrum. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. , 1990, Cerebrovascular and brain metabolism reviews.
[77] R. Roberts,et al. Short‐ and long‐term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: A light and electron microscopic study , 1989, Synapse.
[78] W. Pulsinelli. Selective neuronal vulnerability: morphological and molecular characteristics. , 1985, Progress in brain research.